Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Greenlane Regains Full Compliance with Nasdaq Continued Listing Rules

In This Article:

BOCA RATON, FL / ACCESSWIRE / January 15, 2025 / Greenlane Holdings, Inc. ("Greenlane" or the "Company") (NASDAQ:GNLN), one of the premier global sellers of premium cannabis accessories, child-resistant packaging, and specialty vaporization products, today announced it has regained compliance with Nasdaq Listing Rule 5605(c)(2), which requires Nasdaq listed companies to maintain an audit committee consisting of three independent directors. This development follows the appointment on December 31, 2024 of Mr. Michael C. Howe as an independent director of the Company and as a member of the Company's audit committee, effective immediately. With this appointment, Greenlane is now in full compliance with all Nasdaq continued listing requirements and has remedied all previously announced deficiencies.

Mr. Howe has a proven track record of leading and building successful consumer focused businesses across different sectors including consumer goods, fast food restaurants, SaaS products, and innovative healthcare companies. Mr. Howe has more than 40 years of consumer and healthcare experience including management positions with Procter & Gamble and PepsiCo, and CEO positions at Arby's, Minute Clinic (acquired by CVS in 2006), and several technology companies.

His leadership and expertise in creating innovative consumer focused brands was demonstrated during his tenure at MinuteClinic, a provider of safe, accessible and convenient healthcare services to the consumer. Mr. Howe joined MinuteClinic in June 2005 as the brand struggled to define a clear national expansion strategy. At that time, the company had established 19 clinics in two markets. Within 15 months Mr. Howe added more than 100 clinics in 13 markets and facilitated the sale of the company to CVS in September 2006. He stayed with CVS as CEO of MinuteClinic for two additional years leading the national expansion from the original 19 clinics to more than 530. After leaving CVS in September of 2008, Mr. Howe focused on supporting start up and early-stage companies in their expansion processes, as an angel investor, board member, and executive. His areas of focus include branding, marketing, site development, operational leadership and organizational development. He earned both his accounting and business degrees from the University of Minnesota, Duluth after serving 4 years in the U.S. Air Force.

"Michael will be a tremendous asset to the Board in its oversight of the Company's long-term strategy," said Barbara Sher, Chief Executive Officer for Greenlane. "His exceptional track record in growth-oriented organizations and his strategic insights will be invaluable as we continue to execute on our growth objectives. Michael's appointment reflects our ongoing commitment to enhancing our board with diverse, independent perspectives."